For example, mir-191 is abnormally expressed in several cancers and has been associated with both 5-FU resistance and the regulation of CEBPB expression Zhang et al., 2015; however, the CEBPB–DPYD regulatory axis has not previously been recognized. The gene discussed is DPYD; the disease is cancer.